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Abstract
Background: Excessive loss of bile acids in stool has been reported in patients with cystic fibrosis.
Some data suggest that a defect in mucosal bile acid transport may be the mechanism of bile acid
malabsorption in these individuals. However, the molecular basis of this defect is unknown. This
study examines the expression of the ileal bile acid transporter protein (IBAT) and rates of
diffusional (sodium independent) and active (sodium dependent) uptake of the radiolabeled bile acid
taurocholate in mice with targeted disruption of the cftr gene.
Methods: Wild-type, heterozygous cftr (+/-) and homozygous cftr (-/-) mice were studied. Five
one-cm segments of terminal ileum were excised, everted and mounted onto thin stainless steel
rods and incubated in buffer containing tracer 3H-taurocholate. Simultaneously, adjacent segments
of terminal ileum were taken and processed for immunohistochemistry and Western blots using
an antibody against the IBAT protein.
Results: In all ileal segments, taurocholate uptake rates were fourfold higher in cftr (-/-) and two-
fold higher in cftr (+/-) mice compared to wild-type mice. Passive uptake was not significantly higher
in cftr (-/-) mice than in controls. IBAT protein was comparably increased. Immuno-staining
revealed that the greatest increases occurred in the crypts of cftr (-/-) animals.
Conclusions: In the ileum, IBAT protein densities and taurocholate uptake rates are elevated in
cftr (-/-) mice > cftr (+/-) > wild-type mice. These findings indicate that bile acid malabsorption in
cystic fibrosis is not caused by a decrease in IBAT activity at the brush border. Alternative
mechanisms are proposed, such as impaired bile acid uptake caused by the thick mucus barrier in
the distal small bowel, coupled with a direct negative regulatory role for cftr in IBAT function.
Introduction
Cystic fibrosis (CF) is an autosomal recessive disease
caused by mutations in the gene encoding the CFTR
chloride channel [1]. CFTR is known to possess multiple
cellular functions beyond its role as an apical membrane
chloride channel [2]. For example, regulation of other
ion channels, such as the epithelial sodium channel and
the outwardly rectified chloride channel, are well-de-
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tions, such as regulation of intracellular vesicular pH,
regulation of membrane recycling, and regulation of mu-
cin exocytosis are less firmly established. Phenotypic ex-
pression in CF is variable, with multiple organs affected.
The disease is commonly but variably expressed in the
lungs, the exocrine pancreas, and the gastrointestinal
mucosa [5,6].
Significant intestinal malabsorption of various sub-
strates, including bile acids, is a consistent finding in CF
patients. The total bile acid pool is contracted unless sup-
plementation with pancreatic enzymes is provided. In
children, bile acid losses can be so severe that a deficien-
cy of the amino acid taurine can occur due to excessive
losses of taurine-conjugated bile acids [7,8].
Bile acid malabsorption in CF has been attributed to an
inhibitory effect of un-hydrolyzed, intraluminal triglyc-
erides on the intestinal absorption of bile acids. Howev-
er, in several studies the correlation between fecal fat
excretion and fecal bile acid loss could not be demon-
strated, suggesting that additional factors are responsi-
ble for bile acid malabsorption in cystic fibrosis [9,10]. In
vitro studies using brush border membrane vesicles or
bathed tissue samples from patients with cystic fibrosis
have shown that total ileal bile acid uptake is diminished
[11,12].
The present study was designed to determine if the activ-
ity and density of the ileal bile acid transporter IBAT is
diminished in heterozygous and homozygous cftr knock-
out mice. The results indicate that bile acid malabsorp-
tion in CF is not caused by a defect in sodium-dependent
bile acid transport at the brush border membrane sug-
gesting another mechanism is operative.
Materials and Methods
Animals
Cftr knockout mice, with targeted disruption of the cftr
gene created at the University of North Carolina [13],
were maintained at the University of Washington Animal
Care Facility under the auspices of the UW Cystic Fibro-
sis Research Center. Thirty-five post-weanling mice
more than 20 days old (strain V129Xl/SvJ) were used,
including 6 homozygous cftr (-/-), 23 heterozygous cftr
(+/-) and 6 wild-type cftr (+/+) mice. All mice had been
kept on a standard liquid diet (Peptamen®, Nestle Deer-
field, IL)- for 3 weeks until immediately prior to sacrifice.
On this diet, the mice showed no evidence of obstruction.
Mice underwent inhalation anesthesia with 1.5% meth-
oxyflurane (Metophane®, Mallinckrodt, Mundelein, IL)
for the harvest of the intestines and were sacrificed sub-
sequently by cervical dislocation under a protocol ap-
proved by the Institutional Animal Use Committee.
Geno-typing was performed using DNA isolated from the
mouse tails. Following isolation of genomic DNA by
standard techniques, PCR was performed using primers
specific for wild-type mice and for cftr knockout mice.
The primer sets used and the expected size products
were as follows:
WT: CAGTGAAGCTGAGACTGTGA/GCATAATCCAA-
GAAAATTGAG(1.1 kb) CF: CGGTTCTTTTTGTCAAGAC/
ATCCTCGCCGTCGGGCATGC (400 bp). Wild-type mice
expressed cftr protein by immunoblotting, while cftr (-/-
) did not [14]. All chemicals were from Sigma unless
otherwise stated (Sigma-Aldrich, St. Louis, MO). The in-
vestigators performing the uptake and immunohisto-
chemistry experiments were blinded to the results of the
geno-typing.
Preparation of intestinal segments
Mice were anesthetized and the abdomen opened. A one-
cm segment of jejunum was resected at the ligament of
Treitz. The terminal 8 cm segment of ileum was removed
and immediately transferred into 2°C cold mammalian
Ringer solution (128 mM NaCl, 4.7 mM KCl, 2.5 mM
CaCl2, 1.2 mM NaH2PO4 1.2 mM MgSO4, and 20 mM
NaHCO3, pH at 37°C = 7.30 - 7.40, 290 mosm, gassed
continuously with 95% O2/5% CO2). The intestinal
length was measured and the tissue cut into 2 one-cm
segments, 1 five-cm segment and another one-cm seg-
ment beginning distally. The five-cm gut segment locat-
ed 2 cm to 7 cm proximal to ileocecal valve was used for
uptake experiments. The segment was cut into five one-
cm pieces. These specimens were everted and the intes-
tinal sleeves secured onto 1 mm diameter stainless steel
rods using 3–0 silk ties as described previously [15]. The
distal ileal segments from 1–2 cm proximal to the ileoce-
cal valve (immediately adjacent to the tissue used in the
uptake experiments) and the jejunal segments were used
for immunohistochemistry studies. The ileal segments
from 7–8 cm and 0–1 cm proximal to the ileocecal valve,
respectively, from each animal were pooled and used for
Western blots.
Uptake measurements
All uptake measurements were performed between 1 and
2 hours after excision. Samples were randomized into 2
groups. Intestines from the first group were exposed to
an identical radioactive taurocholate solution containing
sodium. Samples from the second group were exposed to
a sodium-free taurocholate solution. Mounted tissues
were preincubated for 5 min. in 37°C warm, oxygenated
Ringer's solution. Then rods were suspended with the
tissue positioned 5 mm above stirring bars rotating at
1,200 rpm and uptake was measured for 2 min. in 37°C
warm, oxygenated Ringer's solution with 1 mM tauro-
cholate. To the uptake solutions tracer amounts of radi-
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taurocholate, 74 GBq/mmol, NEN Research Products,
Boston, MA) were added. 1,2-14C polyethylene glycol
(MW 4000 Dalton; 9.3 MBq/mmol, NEN Research
Products, Boston, MA), a marker substance not subject
to carrier-mediated transport and with a very low diffu-
sion coefficient, was added to these solutions to account
for 3H-radiotracer in the adherent fluid. The incubation
time was chosen based on validation experiments that
showed that PEG equilibrated in the unstirred layer after
two minutes. In contrast, taurocholate uptake rates re-
mained linear for at least four minutes (data not shown).
To measure Na-independent uptake, Na-free Ringer's
solution was prepared by replacing NaCl with Choline-Cl
and NaHCO3 with KHCO3. In the Na-free solutions, tau-
rocholate was added as a potassium salt. Potassium-tau-
rocholate was prepared by ion exchange of a 1 M solution
Na-taurocholate with potassium-loaded AmberLyte
(Biorad, Hercules, CA). The potassium salt was subse-
quently recrystallized. Absence of sodium ions following
the ion exchange was confirmed by flame-photometry.
After incubation, tissues were removed from the rods,
placed in scintillation vials and solubilized in TS-2 tissue
solubilizer (Research Products International, Mount
Prospect, IL). Then 5 ml Safety-Solve scintillation cock-
tail (Research Products International) were added. Beta
emissions (in disintegrations per minute {DPM}) from
tritium and 14C were calculated from CPM counted in a
dual channel liquid scintillation counter (Tricarb 2200
CA, Packard Instrument Co., Downers Grove, IL) based
on appropriate standard spectra and quench curves for
the dual-labeled samples. Calculations of uptake rates
were performed as described previously [15,16].
Immunohistochemistry studies
Polyclonal rabbit antibodies were obtained from a com-
mercial source (Research Genetics, Huntsville, AL)
against a C-terminal 14 amino acid oligopeptide frag-
ment of IBAT and purified by immuno-affinity chroma-
tography as described [17]. The ileal tissue segments
were snap-frozen in -70°C cold isopentane and then
stored in -70°C until the tissues were processed. Frozen
sequential 10 micron cross-sections were cut in the cryo-
stat at -25°C. The cryo-sections were air-dried at room
temperature, fixed in acetone for 5 min., washed for 15
min in Tris-buffered saline (TBS; 20 mM Tris-HCl, 500
mM NaCl, pH 7.4) and incubated for 1 hour with 1% pu-
rified milk protein blocking solution (Boehringer-Man-
nheim, Indianapolis, IN) in TBS to reduce background
staining. A 1:20 dilution of anti-IBAT protein antibodies
was applied for one hour. Pre-immune serum served as a
negative control. Sections were washed and incubated
for one hour with a 1:200 dilution of a secondary goat
anti-rabbit Cy3-IgG antibody (Jackson Immuno-Re-
search Laboratories, West Grove, PA), then washed in 1
× TBS for 2 × 10 min. Slides were mounted using an aque-
ous medium containing Hoechst 33258 dye as a nuclear
stain (Sigma, St. Louis, MO). The distribution of the flu-
orescence signal was evaluated under a fluorescence mi-
croscope (Zeiss, Jena, Germany) with photometer
electronic multiplier (Hamamatsu, Billerica, MA)
equipped with an intensity measuring program for fluo-
rescence. The signal density was quantified as fluores-
cence intensity over background in circular image fields
extending from the villus tip to the crypt base using an
MS2 image analysis system (Imaging Research, St. Cath-
erines, Ontario, Canada).
Western blots
Brush border membrane vesicles were prepared as de-
scribed by deRooij [11]. Briefly, frozen ileal tissue frag-
ments (20–25 mg) were thawed and homogenized in 100
Figure 1
Sodium-Dependent Taurocholate Uptake Rates by Ileal Seg-
ments from Wild-Type, Heterozygous and Cystic Fibrosis
Mice. An increase in active taurocholate uptake was
observed in all examined sections of the terminal ileum of
knock-out mice. Uptakes rates approximately doubled in het-
erozygous knock-out mice (CFTR +/-; n = 23) and quadru-
pled in homozygous mutants (CFTR -/-; n = 6) compared to
wild-type controls (WT; n = 6). Differences were statistically
significant in the 2 cm and 3 cm groups (# = significant differ-
ence when comparing this group to the wild-type group at p
< 0.05; ** = significant difference when comparing this group
to the heterozygous group at p < 0.05). The axial distribution
curves of taurocholate uptake were similar and had peaks at
3–4 cm before the ileocecal valve in all three groups.
0
100
200
300
400
2cm 3cm 4cm 5cm 6cm
Distance from Ileocecal Valve [cm]
Ta
u
ro
ch
ol
at
e 
Up
ta
ke
 
[p
mo
l/m
m
2
x
 m
in
]
WT
CFTR -/+
CFTR-/-
0
50
100
150
200
250
300
350
400
2cm 3cm 4cm 5cm 6cm
Distance from Ileocecal Valve [cm]
Ta
u
ro
ch
ol
at
e 
Up
ta
ke
 
[p
m
o
l/m
m
2
x
 m
in
]
WT
CFTR -/+
CFTR-/-
A
B
#
#
#
#
* *
* *
BMC Gastroenterology 2001, 1:10 http://www.biomedcentral.com/1471-230X/1/10µl of isotonic buffer (300 mM mannitol, 12 mM Tris-HCl,
pH 7.1) using a Polytron homogenizer (Kinematica AG,
Littau, Switzerland). This suspension was cleared form
debris and diluted with five volumes of ice cold water and
MgCl
2
 was added to a final concentration of 10 mM. After
40 minutes this suspension was centrifuged at 3,000 × g
for 15 min. The supernatant was decanted into another
vial and stored at 4°C. The pellet was resuspended in
buffer and after 40 minutes this suspension was centri-
fuged as before. The two supernatant fractions were
combined and centrifuged for 30 min at 27,000 × g to
spin down the brush border membrane vesicles. 10 µl of
the brush border membrane preparation was diluted in
90 µl of Laemmli buffer, boiled for 5 min and separated
on a denaturing polyacrylamide gel (5 % stacking gel/10
% resolving gel) at 120 V over 2 hours [18]. The separated
proteins were transferred onto nitrocellulose membrane
using a Trans-blot instrument (Biorad, Hercules, CA) in
glycine-methanol buffer following the manufacturer's
suggestions. Blots were developed using a 1:100 dilution
of the rabbit anti-hamster IBAT antibodies and an am-
plified alkaline phosphatase goat-anti-rabbit immunob-
lot assay kit (Biorad, Hercules, CA) as recommended by
the manufacturer.
Statistical Analysis
All data were collected from individual tissues and proc-
essed as independent data points as well as grouped by
their origin (2 cm, 3 cm from the ileocecal valve, etc.) Re-
sults were expressed as mean +/- standard error of the
mean (SEM). Comparisons were made between multiple
groups using ANOVA and the unpaired student t-test as
a post-hoc test. Significance was assumed at p < 0.05.
Results
Active rates of taurocholate uptake were twice as high in
the heterozygous cftr (+/-) mice (n = 23) compared to
wild-type mice (n = 6) (average of all data points in the
terminal ileum 109 ± 8 vs. 64 ± 13 cm pmol/mm2; p <
0.05) and fourfold higher in the homozygous cftr (-/-)
mice (n = 6) (212 ± 32 pmol/mm2; p < 0.05 vs. wild-
type). Increases occurred similarly at different sites in
the terminal ileum in locations from 2 cm to 7 cm from
the ileocecal valve (Fig. 1a). However, only differences in
the section at 2 and 3 cm reached a level of significance
of p < 0.05. Differences in rates of passive uptake of tau-
rocholate were not statistically significant among groups
(Fig. 1b). Microscopic morphology of the mucosa was
similar in the different study groups.
Prior to use for Western blotting, brush border mem-
brane vesicle suspensions were tested for enrichment of
brush border enzymes and showed a 4 – 5-fold increase
of alkaline phosphatase and a 10 – 11-fold increase in al-
pha-glucosidase activity using standard methods [19].
On densitometric evaluations of Western blots, IBAT
concentrations were twice as high in heterozygotes as in
controls (17 ± 3 vs. 5 ± 1 density units; p < 0.05) and four
times as high in homozygotes (30 ± 4 vs. 5 ± 1 density
units; p < 0.05) (Fig. 2 and 3). A similar relationship was
found in intensity of IBAT immunostaining on examina-
tions of microscopic sections treated with anti-IBAT an-
tibodies. The highest increases in signal density were
noted at the base of the crypts of cftr (-/-) animals (arrow
in Fig. 4). These unusual changes were never found in
any jejunal samples and occurred only occasionally as
weak signals in ileal samples from wild-type animals.
Discussion
Untreated children and adults with cystic fibrosis excrete
amounts of fecal bile acids similar to patients with ileal
resections [20,21]. Based on kinetic studies, this in-
creased fecal loss appears to be secondary to an inter-
rupted enterohepatic circulation of bile acids [20,21].
Bile acid malabsorption in cystic fibrosis appears to be
due in part to diminished secretion of pancreatic en-
zymes and the presence of un-hydrolyzed triglycerides.
Supplementation with pancreatic enzymes and a low-fat
diet can markedly reduce the fecal excretion of bile acids
[9,10,20,23]. Other evidence, however, suggests that a
diminished capacity of the ileal mucosa for bile acid up-
take plays a significant role in bile acid malabsorption as-
sociated with cystic fibrosis that is independent of
triglyceride concentrations. Findings supporting this no-
tion include: 1. The absence of a correlation between fe-
cal fat excretion and fecal bile acid loss; 2. The normal
fecal bile acid losses in patients with liver disease com-
pared to excessive losses in those without liver disease
despite similar fecal fat excretion; and 3. The finding that
Figure 2
Western Blot of Ileal Brush Border Proteins from Wild-
Type, Heterozygous and Cystic Fibrosis Mice. An increase in
IBAT protein concentration was observed in all examined
brush border membrane vesicle preparations of the terminal
ileum in knock-out mice. IBAT content approximately dou-
bled in heterozygous knock-out mice and quadrupled in
homozygous mutants compared to wild-type controls.
Wild-type CFTR (+/-) CFTR (-/-)
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lose large amounts of bile acids.
Based on these findings, a defect in ileal bile acid trans-
port mechanisms in cystic fibrosis has been suspected.
Data in support of this hypothesis are contradictory.
Fondacaro et al. bathed ileal biopsies from CF patients in
taurocholate solutions. They found a decrease in total
(apical + basolateral) bile acid uptake compared to nor-
mal controls [12] and hypothesized that bile acid malab-
sorption in cystic fibrosis was due to a primary mucosal
defect although they had not specifically studied apical,
Na+-dependent absorption. De Rooij et al. found signifi-
cant decreases in active bile acid uptake when examining
ileal brush border membrane vesicles [11] and proposed
that altered viscosity of the ileal mucus was likely not a
factor in ileal bile acid malabsorption associated with
cystic fibrosis. In another study using marker perfusions
with taurocholate and glycocholate in three infants, how-
ever, the bile acid uptake rates with cystic fibrosis were
similar to control subjects [24].
The results from our study stand in contrast to these ear-
lier studies. We found a significant increase in bile acid
transport in cftr (-/-) and cftr (+/-) mice. This increase in
IBAT function was paralleled by increases in IBAT pro-
tein concentrations. Similar discrepancies between
measurements of solute uptake with brush border mem-
brane vesicles or tissue biopsies and in vivo experiments
have been observed in studies examining sodium/glu-
cose cotransport in cystic fibrosis. Jejunal glucose ab-
sorption was enhanced in patients with cystic fibrosis
when measured with catheter perfusion techniques [25].
Ussing chamber studies of intact CF biopsy specimens
suggest that glucose and alanine uptake rates are mark-
edly increased in cystic fibrosis [26]. Taylor also studied
intact jejunal biopsies and found that the rate of active
sodium/glucose transport approximately doubled in CF
compared to normal jejunum [27].
Contrary to these findings, other investigations have
been unable to demonstrate any changes in sodium/glu-
cose co-transport when examining brush border mem-
brane vesicles [28]. The up-regulation of intestinal
sodium-linked nutrient absorption by cftr may occur via
a mechanism that does not involve changes of the brush
border membrane but rather intracellular components
[28]. Intestinal sodium-linked nutrient absorption
would then be undetectable in brush border membrane
vesicle studies. However, a number of studies using bi-
opsies in Ussing chambers have also been unable to dem-
onstrate enhanced glucose absorption in cystic fibrosis
[29–31].
Phenotypic expression is variable in patients carrying
homozygous or heterozygous mutations of the CFTR
gene. The ∆F508 mutation is the most common genetic
disturbance affecting the CFTR gene. ∆F508 heterozy-
gotes are affected to a lesser degree than are homozy-
gotes. In heterozygous infants with the WT/∆F508
genotype, sweat chloride excretion is elevated 1.5-fold
over normal values compared to a tenfold increase in ho-
mozygous patients with the ∆F508/∆F508 genotype
[32]. Adult heterozygous patients have fewer problems
with respiratory infections compared to homozygotes
[5]. Our findings that bile acid absorption was moderate-
ly increased in heterozygotes and markedly increased in
homozygotes were therefore not unexpected. Heterozy-
gotes are able to produce a limited number of intact, cor-
rectly localized CFTR protein molecules resulting in
partial phenotypic expression. The correlation between
zygosity and level of IBAT protein expression suggests a
close relationship between the function of the CFTR
chloride channel and the sodium-dependent ileal bile
acid transporter.
Our study is the first that correlates changes in function
of another intestinal solute transporter with the expres-
sion level of CFTR. Increased bile acid transport in cftr (-
/-) mice is associated with an increase in the abundance
of IBAT protein in the brush border membrane. Similar
associations exist in normal rodents. In hamsters, rats
and mice, increases and decreases in bile acid absorption
at the brush border membrane are mediated by an up- or
down-regulation in IBAT gene transcription [33,34]. In
several rodent species including mice, regulation of IBAT
is clearly dependent on intraluminal bile acid concentra-
Figure 3
Quantification of Western Blot for IBAT in Figure 3 from
Wild-Type, Heterozygous and Cystic Fibrosis Mice. IBAT
band density approximately doubled in heterozygous knock-
out mice (n = 23) and quadrupled in homozygous mutants (n
= 6) compared to wild-type controls (n = 6) (# = significant
difference when comparing this group to the wild-type group
at p < 0.05; ** = significant difference when comparing this
group to the heterozygous group at p < 0.05).
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[33–35]. Feeding of bile acids suppresses transcription
of IBAT mRNA and reduces IBAT protein abundance;
feeding of the bile acid binder cholestyramine has the op-
posite effect. In normal animals, this negative feedback
mechanism keeps the enterohepatic bile acid pool in
equilibrium. As bile acids are lost, increased absorption
by a greater number of transporters, in combination with
increased hepatic bile acid synthesis from cholesterol,
helps restore normal bile acid levels. In contrast, cftr (-/
-) mice may experience bile acid malabsorption even
though their ileal mucosal cells express four-fold more
IBAT transporters than normal cells. This apparently
paradoxical finding would suggest a luminal factor that
prevents bile acids from entering the mucosal cells in the
ileum.
Based on this evidence, we postulate that the more vis-
cous mucus layer in the ileal crypts of individuals with
cystic fibrosis limits access of luminal bile acids and mi-
celles to the ileal crypt cells. This may result in an altered
programming of ileal stem cells and transit cells that give
rise to absorptive enterocytes over-expressing IBAT pro-
tein.
Further investigations are needed to corroborate this hy-
pothesis. Additional studies should examine changes in
mucus layer thickness, mucus viscosity and permeability
for bile acids associated with hetero- and homozygosity
for CFTR mutations. An alternative mechanism for the
upregulation of IBAT in cystic fibrosis is that CFTR acts
as a negative regulator of IBAT, as it does for the epithe-
lial sodium channel [36]. As IBAT is a sodium-depend-
ent apical membrane transporter, it might be regulated
by CFTR, as is the epithelial sodium channel (ENaC)
present in the apical membrane of the ileal enterocyte.
CFTR regulation of ENaC has been described in the co-
lon in humans [37] and in cftr knockout mice [37]. Co-lo-
calization of CFTR and ENaC suggests that direct
protein-protein interactions allow CFTR to closely regu-
late the activity of this channel [39,40]. Our results sug-
gest that knockout of CFTR leads to an analogous
increase in expression and function of IBAT. Of course, a
more widespread perturbation of ion channel regulation
in the absence of CFTR is also a possibility, as CFTR has
been demonstrated to be a master regulator of such di-
verse proteins as the Na/K pump [41], the basolateral
Na/K/2Cl co-transporter [42], and the inducible nitric
oxide synthase [43].
Conclusions
In summary, in the widely studied cftr knockout mouse
model (which clearly demonstrates intestinal patholo-
gy), the apical sodium dependent ileal bile acid trans-
porter is expressed and functions at higher levels than in
wild-type animals, with intermediate levels of IBAT ex-
pression and function in heterozygous cftr (+/-) mice.
The results of this study open up further avenues of in-
vestigation with respect to the role of the mucus layer in
causing a secondary up-regulation of IBAT expression
and function. In addition, IBAT may be yet another api-
cal membrane transport protein that is regulated by
CFTR.
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Figure 4
Staining of IBAT protein in the Ileal Mucosal Brush Border
from Wild-Type, Heterozygous and Cystic Fibrosis Mice. An
increase in IBAT protein staining intensity was observed in
microscopic sections of the terminal ileum of knock-out
mice. IBAT signal intensities were higher in heterozygous
knock-out mice and still higher in homozygous mutants com-
pared to wild-type controls. Jejunal mucosa showed no IBAT
signals.
CFTR (+/-)
CFTR (-/-)
Wild-type
Ileum Jejunum
BMC Gastroenterology 2001, 1:10 http://www.biomedcentral.com/1471-230X/1/10Acknowledgements
The authors wish to express their gratitude to J. Donald Ostrow for a crit-
ical review of the manuscript and for his helpful advice. The authors also 
thank Dr. Christopher Wilson, Dept. of Immunology, University of Wash-
ington, for providing mice from his colony.
References
1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak
Z, Zielenski J, Lok S, Plavsic N, Chou JL: Identification of the cystic
fibrosis gene: cloning and characterization of complementa-
ry DNA. Science 1989, 245:1066-1073
2. Jentsch TJ: Chloride channels: a molecular perspective. Curr
Opin Neurobiol 1996, 6:303-310
3. Schwiebert EM, Egan ME, Hwang TH, Fulmer SB, Allen SS, Cutting
GR, Guggino WB: CFTR regulates outwardly rectifying chlo-
ride channels through an autocrine mechanism involving
ATP. Cell 1995, 81:1063-1073
4. Kunzelmann K, Schreiber R, Nitschke R, Mall M: Control of epithe-
lial Na+ conductance by the cystic fibrosis transmembrane
conductance regulator. Pflugers Arch 2000, 440:193-201
5. Rosenecker J: Relations between the frequency of the DeltaF
508 mutation and the course of pulmonary disease in cystic
fibrosis patients infected with Pseudomonas aeruginosa. Eur
J Med Res 2000, 5:356-359
6. Colombo C, Roda A, Roda E, Piceni Sereni L, Brega A, Fugazza R,
Giunta A: Bile acid malabsorption in cystic fibrosis with and
without pancreatic insufficiency. J Pediatr Gastroenterol Nutr 1984,
3:556-562
7. Thompson GN: Excessive fecal taurine loss predisposes to tau-
rine deficiency in cystic fibrosis. J Pediatr Gastroenterol Nutr 1988,
7:214-219
8. Carrasco S, Codoceo R, Prieto G, Lama R, Polanco I: Effect of tau-
rine supplements on growth, fat absorption and bile acid on
cystic fibrosis. Acta Univ Carol [Med] (Praha) 1990, 36:152-156
9. Watkins JB, Tercyak AM, Szczepanik P, Klein PD: Bile salt kinetics
in cystic fibrosis: influence of pancreatic enzyme replace-
ment. Gastroenterology 1977, 73:1023-1028
10. Smalley CA, Brown GA, Parkes ME, Tease H, Brookes V, Anderson
CM: Reduction of bile acid loss in cystic fibrosis by dietary
means. Arch Dis Child 1978, 53:477-482
11. de Rooij FW, van den Berg JW, Sinaasappel M, Bosman-Jacobs EP,
Touw-Blommesteijn AC: Bile acid malabsorption in cystic fibro-
sis; membrane vesicles, a tool for revealing the role of the
ileal brush border membrane. Acta Paediatr Scand Suppl 1985,
317:28-30
12. Fondacaro JD, Heubi JE, Kellogg FW: Intestinal bile acid malab-
sorption in cystic fibrosis: a primary mucosal cell defect. Pedi-
atr Res 1982, 16:494-498
13. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC,
Smithies O, Koller BH: An animal model for cystic fibrosis
made by gene targeting. Science 1992, 257:1083-1088
14. Kuver R, Savard C, Nguyen TD, Osborne WR, Lee SP: Isolation and
long-term culture of gallbladder epithelial cells from wild-
type and CF mice. In Vitro Cell Dev Biol Anim 1997, 33:104-109
15. Karasov WH, Diamond JM: A simple method for measuring in-
testinal solute uptake in vitro. J Comp Physiol 1983, 152:105-116
16. Stelzner M, Hoagland V, Somasundaram S: A simple method for
measuring of intestinal solute transport in mucosal biopsy
specimens. Dig Dis Sci 2001, 46:451-461
17. Stelzner M, Hoagland V, Somasundaram S: Distribution of bile acid
absorption and bile acid transporter gene message in the
hamster ileum. Pflugers Arch – Europ J Physiol 2000, 440:157-162
18. Sambrook J, Fritsch E, Maniatis T: Molecular cloning. A laboratory
manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
Press; 1989
19. Weber AM, Roy CC, Morin CL, Lasalle R: Malabsorption of bile
acids in children with cystic fibrosis. N Engl J Med 1973,
289:1001-1005
20. Peters T, Heath J, Wansbury-Jones M, Doe W: Enzyme activities
and properties of lysosomes and brush border in jejunal bi-
opsies of control subjects and patients with coeliac disease.
Clin Sci and Molecular Med 1975, 48:250-267
21. O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, Fit-
zGerald MX, Hegarty JE: Intestinal bile acid malabsorption in
cystic fibrosis. Gut 1993, 34:1137-1141
22. Harries JT, Muller DP, McCollum JP, Lipson A, Roma E, Norman AP:
Intestinal bile salts in cystic fibrosis: studies in the patient
and experimental animal. Arch Dis Child 1979, 54:19-24
23. Roller RJ, Kern F: Minimal bile acid malabsorption and normal
bile acid breath tests in cystic fibrosis and acquired pancre-
atic insufficiency. Gastroenterology 1977, 72:661-665
24. Thompson GN, Davidson GP: In vivo bile acid uptake from ter-
minal ileum in cystic fibrosis. Pediatr Res 1988, 23:323-328
25. Frase LL, Strickland AD, Kachel GW, Krejs GJ: Enhanced glucose
absorption in the jejunum of patients with cystic fibrosis. Gas-
troenterology 1985, 88:478-484
26. Baxter P, Goldhill J, Hardcastle J, Hardcastle PT, Taylor CJ: En-
hanced intestinal glucose and alanine transport in cystic fi-
brosis. Gut 1990, 31:817-820
27. Taylor CJ, Baxter PS, Hardcastle J, Hardcastle PT, Goldhill J: Glucose
intolerance in cystic fibrosis [letter]. Arch Dis Child 1989, 64:759
28. Beesley AH, Hardcastle J: Sodium/glucose cotransporter activi-
ty in cystic fibrosis. Arch Dis Childhood 1996, 75:169-172
29. Berschneider HM, Knowles MR, Azizkhan RG, Boucher RC, Tobey
NA, RC Orlando, Powell DW: Altered intestinal chloride trans-
port in cystic fibrosis. Faseb J 1988, 2:2625-2629
30. Taylor CJ, Baxter PS, Hardcastle J, Hardcastle PT: Absence of se-
cretory response in jejunal biopsy samples from children
with cystic fibrosis [letter]. Lancet 1987, 2:107-108
31. Taylor CJ, Baxter PS, Hardcastle J, Hardcastle PT: Failure to induce
secretion in jejunal biopsies from children with cystic fibro-
sis. Gut 1988, 29:957-962
32. Farrell PM, Koscik RE: Sweat chloride concentrations in infants
homozygous or heterozygous for F508 cystic fibrosis. Pediat-
rics 1996, 97:524-528
33. Lillienau J, Crombie DL, Munoz J, Longmire-Cook SJ, Hagey LR, Hof-
mann AF: Negative feedback regulation of the ileal bile acid
transport system in rodents. Gastroenterology 1993, 104:38-46
34. Torchia EC, Cheema SK, Agellon LB: Coordinate Regulation of
bile acid biosynthetic and recovery pathways. Biochem Biophys
Res 1996, 225:128-133
35. Stelzner M: Unpublished data. 
36. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC,
Boucher RC: CFTR as a cAMP-dependent regulator of sodium
channels. Science 1995, 269:847-850
37. Mall M, Bleich M, Kuehr J, Brandis M, Greger R, Kunzelmann K:
CFTR-mediated inhibition of epithelial Na+ conductance in
human colon is defective in cystic fibrosis. Am J Physiol 1999,
277:G709-716
38. Grubb BR, Boucher RC: Enhanced colonic Na+ absorption in
cystic fibrosis mice versus normal mice. Am J Physiol 1997,
272:G393-400
39. Ji HL, Chalfant ML, Jovov B, Lockhart JP, Parker SB, Fuller CM, BA
Stanton, Benos DJ: The cytosolic termini of the beta- and gam-
ma-ENaC subunits are involved in the functional interac-
tions between cystic fibrosis transmembrane conductance
regulator and epithelial sodium channel. J Biol Chem 2000,
275:27947-27956
40. Berdiev BK, Shlyonsky VG, Karlson KH, Stanton BA, Ismailov II: Gat-
ing of amiloride-sensitive Na(+) channels: subunit-subunit in-
teractions and inhibition by the cystic fibrosis
transmembrane conductance regulator. Biophys J 2000,
78:1881-1894
41. Ito Y, Mizuno Y, Aoyama M, Kume H, Yamaki K: CFTR-Mediated
anion conductance regulates Na(+)-K(+)-pump activity in
Calu-3 human airway cells. Biochem Biophys Res Commun 2000,
274:230-235
42. Shumaker H, Soleimani M: CFTR upregulates the expression of
the basolateral Na(+)-K(+)-2Cl(-) cotransporter in cultured
pancreatic duct cells. Am J Physiol 1999, 277:C1100-1110
43. Steagall WK, Elmer HL, Brady KG, Kelley TJ: Cystic fibrosis trans-
membrane conductance regulator-dependent regulation of
epithelial inducible nitric oxide synthase expression. Am J
Respir Cell Mol Biol 2000, 22:45-50
